UroGen Pharma URGN
NASDAQ URGN
$35.50 +0.02 (+0.06%)
As of: Oct 22, 2026 · 10:05 AM EDT

UroGen Pharma (URGN) Long-Term Debt Repayments (2025 - 2026)

Updated

UroGen Pharma (URGN) reported Long-Term Debt Repayments of $387,000 for Q2 2026, up 20.6% from the prior quarter.

Analysis

UroGen Pharma (URGN) Long-Term Debt Repayments (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, UroGen Pharma's Long-Term Debt Repayments came in at $1.4 million; for FY2025, it came in at $1.86 million.

  • The Q2 2026 figure ranks as the highest quarterly Long-Term Debt Repayments since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,163.48 Bn 1,132.06 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 631.16 Bn 549.69 Bn 17.26 Bn 1.00 Mn
3 AbbVie 502.63 Bn 475.74 Bn 12.70 Bn 2.00 Bn
4 Merck 378.53 Bn 332.91 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.83 Bn 266.82 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 265.92 Bn 239.60 Bn 12.86 Bn 2.46 Bn
7 Amgen 240.87 Bn 196.27 Bn 7.24 Bn -
8 Gilead Sciences 194.04 Bn 168.24 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 UroGen Pharma 1.80 Bn 1.30 Bn 65.88 Mn 387,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 387,000.00
Mar 31, 2026 321,000.00
Mar 31, 2025 688,000.00
API Access

UroGen Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=URGN&period=max&api_key=YOUR_API_KEY